Union Bancaire Privee UBP SA Increases Stake in DexCom

The Swiss private bank boosts its holdings in the medical device company by 289.2% in Q4 2025.

Mar. 22, 2026 at 11:14am

Got story updates? Submit your updates here. ›

Union Bancaire Privee UBP SA, a Swiss private bank, has increased its stake in DexCom, Inc. (NASDAQ:DXCM) by 289.2% in the fourth quarter of 2025. The firm now owns 21,266 shares of the medical device company's stock, worth $1.41 million as of its most recent SEC filing.

Why it matters

DexCom is a leading manufacturer of continuous glucose monitoring (CGM) systems, which are critical devices for people with diabetes. The increase in UBP's stake suggests the bank sees strong growth potential in DexCom's business and technology.

The details

According to the SEC filing, UBP added 15,802 shares to its DexCom holdings during Q4 2025, bringing its total position to 21,266 shares. This represents a 289.2% increase in the bank's stake in the medical device company.

  • Union Bancaire Privee UBP SA increased its DexCom stake in the 4th quarter of 2025.

The players

Union Bancaire Privee UBP SA

A Swiss private bank that has increased its holdings in medical device company DexCom, Inc.

DexCom, Inc.

An American medical device company that develops and manufactures continuous glucose monitoring (CGM) systems for people with diabetes.

Got photos? Submit your photos here. ›

The takeaway

The significant increase in UBP's stake in DexCom suggests the bank sees strong growth potential in the medical device company's CGM technology and business. This could signal increased institutional investor confidence in DexCom's future performance.